Is EPIX or NOBL a better dividend investment in 2026?

EPIX currently yields 840.47% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: EPIX offers higher current income.

What is the dividend yield difference between EPIX and NOBL?

EPIX has a forward dividend yield of 840.47% ($1.69/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 838.30 percentage points.

Home › Compare › EPIX vs NOBL

EPIX vs NOBL: Dividend Comparison 2026

EPIX yields 840.47% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EPIX wins by $4215412.26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EPIX

● Live price

840.47%

Share price

$0.20

Annual div

$1.69

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4215412.28M

Annual income

$3,415,908,279,597.25

Full EPIX calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — EPIX vs NOBL

📍 EPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EPIX	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EPIX + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EPIX pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPIX

Annual income on $10K today (after 15% tax)

$71,440.13/yr

After 10yr DRIP, annual income (after tax)

$2,903,522,037,657.66/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, EPIX beats the other by $2,903,522,037,445.35/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPIX + NOBL for your $10,000?

EPIX: 50%NOBL: 50%

100% NOBL50/50100% EPIX

Portfolio after 10yr

$2107706.15M

Annual income

$1,707,954,139,923.51/yr

Blended yield

81.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPIX right now

EPIX

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$9.50

+4621.7% upside vs current

Range: $2.00 — $17.00

Altman Z

1.1

Piotroski

3/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPIX buys

NOBL buys

No recent congressional trades found for EPIX or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEPIXNOBL

Forward yield	840.47% ✓	2.17%
Annual dividend / share	$1.69	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4215412.28M ✓	$22.9K
Annual income after 10y	$3,415,908,279,597.25 ✓	$249.78
Total dividends collected	$4152700.41M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EPIX vs NOBL ($10,000, DRIP)

Year	EPIX Portfolio	EPIX Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$94,747	$84,047.22	$10,917	$217.08	+$83.8K → EPIX
2	$845,608	$744,228.02	$11,903	$221.48	+$833.7K → EPIX
3	$7,112,413	$6,207,612.95	$12,962	$225.68	+$7.10M → EPIX
4	$56,406,815	$48,796,533.54	$14,099	$229.68	+$56.39M → EPIX
5	$422,031,389	$361,676,096.60	$15,319	$233.49	+$422.02M → EPIX
6	$2,980,575,750	$2,529,002,163.86	$16,628	$237.10	+$2980.56M → EPIX
7	$19,881,694,862	$16,692,478,809.61	$18,033	$240.53	+$19881.68M → EPIX
8	$125,334,964,899	$104,061,551,396.31	$19,539	$243.78	+$125334.95M → EPIX
9	$747,200,001,618	$613,091,589,175.98	$21,154	$246.86	+$747199.98M → EPIX
10	$4,215,412,281,328	$3,415,908,279,597.25	$22,884	$249.78	+$4215412.26M → EPIX

EPIX vs NOBL: Complete Analysis 2026

EPIX — Stock

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Full EPIX Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this EPIX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPIX vs SCHD EPIX vs JEPI EPIX vs O EPIX vs KO EPIX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.